Japan Set to Push Central IRBs for Clinical Trials, Avoid Customary All-Case PMS

MHLW Pharma Regulation Panel Meeting on March 21 A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the use of central institutional review boards (IRBs) in a bid to boost...read more